In this brand-new interview, Ignacio Quiles Lara, VP and Commercial Director, Spain, Onco-Haematology, GSK, delves into the evolving commercial landscape of onco-haematology and discusses machine learning in oncology.
https://t.co/IbcIHnVJDA
The June issue of GOLD is out now! This issue explores the adoption of virtual events during the COVID-19 pandemic, the role of the Chief Digital Officer, the use of RWE in marketing, and so much more. https://t.co/HSuyC50iIz
#toldbyGOLD#Marketing#Medicalaffairs#Pandemic
Events around the world were brought to a grounding halt when the COVID-19 pandemic forced us into lockdown. But many industries including pharma, have been agile and adaptable, utilising virtual events. #toldbyGOLD
https://t.co/SJ1pAJh7lq
The latest issue of our flagship journal is out now! In this issue, we proudly present our review of the virtual European Conference on Rare Diseases alongside a wide range of expert peer-reviewed articles from across multiple therapy areas. Read on here: https://t.co/oE89eGDRZ3
NEW INFOGRAPHIC: In, 'Pharma's Response to Coronavirus', we timeline the industry's response to the pandemic, tracking milestones, treatment and vaccine efforts, and industry donations, since the virus sequence was first released. Find it here: https://t.co/gRLk3fA0VC
Interview with Prof Robert Langer, of Massachusetts Institute of Technology (#MIT). He spoke to us about his current research interests in drug delivery and tissue engineering therapies, winning the Queen Elizabeth Prize for Engineering, and more.
https://t.co/V6VaghCVgh
Join us on the 29th of May for this live #webinar and Q&A session, where the speakers will be discussing hypertensive patients with #Covid_19, focussing on current knowledge and the importance of clinical data. Register today: https://t.co/cKB3OzgukL #Medical#Health
For pharma to successfully enter a new era of precision treatments, there must be substantial input from medical affairs. We discuss the skills and knowledge MA require in this space, including how to successfully identify new biomarkers for R&D. https://t.co/RwouWsX3Za
#Medicine
EMG GOLD Podcast: This week, we speak to social media experts, Chloe Partikas and Rick Evans, from Ogilvy Health UK, who share insights from their 2020 Social Check-up, which looked into the social behaviours of the pharma industry. Listen here: https://t.co/FToJWoS0sE
New EMJ #Urology Supplement: The efficacy and safety of onabotulinumtoxinA (BOTOX®, Allergan, Dublin, Ireland) in the treatment of overactive bladder syndrome (OAB) has been established in various studies and is recommended as the third-line therapy. https://t.co/yLC0gZee9p
Alcohol consumption has become deeply embedded in European culture, with one fifth of the European population aged 15 and over drinking heavily per week. It's time to change our attitudes towards #alcohol! 🍺 🍷 #DigestiveHealthMonth
NEW #Dermatology article out now: "This article aims to help non-dermatologist medical professionals regarding the current status of #photoprotection so that they may be better positioned to advise and respond to their patients." https://t.co/9f7j2Ktqvo
This review includes highlights from several different sessions across the meeting in which speakers discussed key studies of #chlormethine (CL) gel as a therapeutic strategy in treating mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) https://t.co/qFo1ZmqP8R #Dermatology
“A big advantage of #allergy diagnostics with a nasal smear is that it is a good option for small children as compared to blood samples or skin prick testing.” https://t.co/GbKgUVcaSP
EMJ Paper of the Week: #Lupus Panniculitis in Association with Anti-Phospholipid Antibody Syndrome on a Background of Systemic Lupus Erythematosus: A Case Report and Literature Review https://t.co/ociwzZClNI #Allergy#OpenAccess#Medical
This week, on the EMG-Health Podcast, we are exploring the world of #vaccines: their invention and history, the current anti-vax movement, and the role of vaccines in the future.
Listen here: https://t.co/YoYXDBEEnW
We are excited to share the latest edition of our EMJ #Urology 8.1 journal. Read on for up-to-date review articles, case reports, and specialist insights covering the latest in both medical and surgical urological care. https://t.co/iGYXDF719z #MedEd#OpenAccess
WHAT THE EXPERTS HAVE TO SAY: In our interview with @SWexner, the organiser of the ICDS shares with us how the event came to be and his experiences spearheading the National Accreditation Program for Rectal Cancer (NAPRC). https://t.co/wEBlD8Mm54